Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

BCR-ABL Tyrosine Kinase Inhibitors Interfere with the PI3K/Akt Signalling Pathway and Activate the Microphthalmia-Associated Transcription Factor (MITF) in Human Dendritic Cells

Daniela Doerfel, MD, Michael Gutknecht, Melanie Märklin, Lothar Kanz, MD, Helmut R. Salih, MD, Frank Gruenebach, Martin R Müller, MD PhD, Susanne M Rittig, MD

Blood (2014) 124 (21): 1416.

https://doi.org/10.1182/blood.V124.21.1416.1416

Published: 2014

Journal Articles

Inhibition of PI3K/Akt and Erk Signaling Pathways by BCR-ABL Tyrosine Kinase Inhibitors up-Regulates the Immunosuppressive Receptor Osteoactivin in Monocyte-Derived Dendritic Cells

Michael Gutknecht, Simone Joas, Lothar Kanz, MD, Helmut R Salih, MD, Susanne M Rittig, MD, Frank Gruenebach, PhD

Blood (2012) 120 (21): 1050.

https://doi.org/10.1182/blood.V120.21.1050.1050

Published: 2012

Journal Articles

Immunosuppressive Drugs up-Regulate the Immunoinhibitory Receptor Osteoactivin On Human Monocyte-Derived Dendritic Cells

Sabine Braun, Michael Gutknecht, Mark-Alexander Schwarzbich, MD, Lothar Kanz, MD, Helmut R Salih, MD, Frank Grünebach, PD, Susanne M Rittig, MD

Blood (2012) 120 (21): 3284.

https://doi.org/10.1182/blood.V120.21.3284.3284

Published: 2012

Journal Articles

Monocyte-Derived Dendritic Cells Induce Functionally Active Regulatory T Cells Upon Exposure to BCR-ABL Tyrosine Kinase Inhibitors.

Michael Gutknecht, Simone Joas, Lisa Güttler, Lothar Kanz, MD, Helmut R Salih, MD, Frank Grünebach, PD, Susanne M Rittig, MD

Blood (2012) 120 (21): 2156.

https://doi.org/10.1182/blood.V120.21.2156.2156

Published: 2012

Journal Articles

Immunosuppressive Drugs Upregulate the Immunoinhibitory Receptor Osteoactivin in Monocyte-Derived Dendritic Cells,

Mark-Alexander Schwarzbich, MD, Michael Gutknecht, Lisa Guettler, Lothar Kanz, MD, Helmut R. Salih, MD, Frank Gruenebach, PhD, Susanne Malaika Rittig, MD

Blood (2011) 118 (21): 3232.

https://doi.org/10.1182/blood.V118.21.3232.3232

Published: 2011

Journal Articles

Upregulation of Osteoactivin Upon Exposure to Tyrosine Kinase Inhibitors Impairs the T Cell Stimulatory Capacity of Monocyte-Derived Dendritic Cells

Michael Gutknecht, Lisa Güttler, Mark-Alexander Schwarzbich, MD, Julia Salih, Lothar Kanz, MD, Helmut R. Salih, MD, Susanne Malaika Rittig, MD, Frank Grünebach, PD

Blood (2011) 118 (21): 1112.

https://doi.org/10.1182/blood.V118.21.1112.1112

Published: 2011

Journal Articles

The Immune-Inhibitory Receptor Osteoactivin Is up-Regulated In Monocyte-Derived Dendritic Cells Upon Exposure to Tyrosine Kinase Inhibitors

Michael Gutknecht, Mark-Alexander Schwarzbich, Julia Salih, Lothar Kanz, MD, Helmut R. Salih, MD, Susanne M. Schmidt, Frank Grünebach

Blood (2010) 116 (21): 1733.

https://doi.org/10.1182/blood.V116.21.1733.1733

Published: 2010

NARROW

BCR-ABL Tyrosine Kinase Inhibitors Interfere with the PI3K/Akt Signalling Pathway and Activate the Microphthalmia-Associated Transcription Factor (MITF) in Human Dendritic Cells

Inhibition of PI3K/Akt and Erk Signaling Pathways by BCR-ABL Tyrosine Kinase Inhibitors up-Regulates the Immunosuppressive Receptor Osteoactivin in Monocyte-Derived Dendritic Cells

Immunosuppressive Drugs up-Regulate the Immunoinhibitory Receptor Osteoactivin On Human Monocyte-Derived Dendritic Cells

Monocyte-Derived Dendritic Cells Induce Functionally Active Regulatory T Cells Upon Exposure to BCR-ABL Tyrosine Kinase Inhibitors.

Immunosuppressive Drugs Upregulate the Immunoinhibitory Receptor Osteoactivin in Monocyte-Derived Dendritic Cells,

Upregulation of Osteoactivin Upon Exposure to Tyrosine Kinase Inhibitors Impairs the T Cell Stimulatory Capacity of Monocyte-Derived Dendritic Cells

The Immune-Inhibitory Receptor Osteoactivin Is up-Regulated In Monocyte-Derived Dendritic Cells Upon Exposure to Tyrosine Kinase Inhibitors

Email alerts

ASH Publications

American Society of Hematology

BCR-ABL Tyrosine Kinase Inhibitors Interfere with the PI3K/Akt Signalling Pathway and Activate the Microphthalmia-Associated Transcription Factor (MITF) in Human Dendritic Cells

Inhibition of PI3K/Akt and Erk Signaling Pathways by BCR-ABL Tyrosine Kinase Inhibitors up-Regulates the Immunosuppressive Receptor Osteoactivin in Monocyte-Derived Dendritic Cells

Immunosuppressive Drugs up-Regulate the Immunoinhibitory Receptor Osteoactivin On Human Monocyte-Derived Dendritic Cells

Monocyte-Derived Dendritic Cells Induce Functionally Active Regulatory T Cells Upon Exposure to BCR-ABL Tyrosine Kinase Inhibitors.

Immunosuppressive Drugs Upregulate the Immunoinhibitory Receptor Osteoactivin in Monocyte-Derived Dendritic Cells,

Upregulation of Osteoactivin Upon Exposure to Tyrosine Kinase Inhibitors Impairs the T Cell Stimulatory Capacity of Monocyte-Derived Dendritic Cells

The Immune-Inhibitory Receptor Osteoactivin Is up-Regulated In Monocyte-Derived Dendritic Cells Upon Exposure to Tyrosine Kinase Inhibitors

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only